Search results for: 'drug eluting b'
- Did you mean
- drug editing b
- Related search terms
- Drug Discovery and Early Development Outsourcing Market
- drug 01 00 00 00
- drug discovery ad earth development outsourcing market
- drug discovery and east development outsourcing market
- drug discovery ad east development outsourcing market
-
11 Mar 2020  |  North America  |  Market Outlook
Global Homes and Buildings (H&B) Industry Outlook, 2020
Artificial Intelligence (AI)-driven Solutions, Energy Efficiency Directives, Sustainability Targets, Construction Activities, and Stringent Building Safety Codes Drive Overall Industry Growth
The homes and buildings (H&B) industry is driven by the penetration of IoT at the field level of buildings, by the emerging adoption of artificial intelligence (AI)-driven solutions at the management level, and by cloud-based data analytics. These technologies are significantly impacting the smart homes, LED lighting, building automation, and build...
$4,950.00 -
29 Apr 2019  |  Global  |  Market Outlook
Global Homes and Buildings (H&B) Industry Outlook, 2019
Artificial Intelligence (AI), Voice Command Control, and IoT-enabled Lighting to Drive the Industry Forward
The homes and buildings (H&B) industry continues to evolve, driven by transformational technologies such as artificial intelligence (AI), machine learning, Internet of Things (IoT), data analytics, and the cloud. These technologies are significantly impacting smart homes, LED lighting, building automation, and building energy management markets. Ev...
$4,950.00 -
28 Aug 2020  |  Global  |  Technology Research
Data Science Impacting the Pharmaceutical Industry
Part I: Drug Discovery Applications
Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...
$4,950.00 -
05 May 2020  |  North America  |  Frost Radar
FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020
Benchmarking Future Growth Potential
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...
$4,950.00 -
13 Dec 2022  |  Global  |  Market Outlook
Growth Opportunity Outlook in the Homes and Buildings Industry
The homes and buildings industry’s future is technology enabled. Recovery from the COVID-19 pandemic combined with decarbonization challenges will accelerate the use of digital building technologies. Heightened awareness about a safe and healthy environment will prompt the use of the internet of things (IoT), artificial intelligence (AI) applicatio...
$2,450.00 -
10 Jan 2020  |  Asia Pacific  |  Market Research
Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
$10,000.00 -
31 Jan 2020  |  North America  |  Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00 -
20 Feb 2020  |  Europe  |  Market Outlook
EU Healthcare Predictions and Outlook, 2020
Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth
Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national health...
$4,950.00 -
19 Apr 2021  |  North America  |  Market Outlook
Digital and Outcome-linked Service Innovations to Power the Global Homes and Buildings Industry, Outlook 2021
Future Growth Potential Driven by Resilient and Sustainable Business Models
The COVID-19 pandemic has impacted nearly every sector and has forced various industries to undergo business transformation initiatives to adapt to the new normal environment. The Homes and Buildings (H&B) industry is no exception and is expected to face an acute recovery challenge both from the supply and demand side of the industry in 2021. As ho...
$4,950.00 -
14 Oct 2019  |  North America  |  Technology Research
Innovations in Biomarker Analytics
Tracking the Market Landscape of Companies Striving to Derive Actionable Insights from the Data Deluge through the incorporation of Artificial Intelligence
Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...
$4,950.00